Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii.
Gross
U
U
Institute of Hygiene and Microbiology, University of Würzburg, Germany.
Pohl
F
F
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002478:Cells, Cultured; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma / Q000187:drug effects* / Q000502:physiology; D014123:Toxoplasmosis / Q000188:drug therapy*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D013411:Sulfadiazine; D002981:Clindamycin; D015572:Spiramycin; D011739:Pyrimethamine